SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies’ R3SET forays into wellness arena

20 Dec 2023 Evaluate

Venus Remedies has unveiled a significant transformation of its consumer healthcare division, R3SET. This strategic pivot marks R3SET's foray into the wellness arena, coupled with the expansion of its pain management portfolio, showcasing the company's holistic approach to wellness solutions. According to recent data from Euromonitor, the Indian Consumer Healthcare market was valued at Rs 42,392 crore in 2023 and js projected to grow by a 4-5% CAGR till 2028.

The launch of R3SET Detox Candies, crafted with a blend of natural herbs such as Kalmegh, Punamava, Daru Haldi, Manjistha and Guduchi, positions the brand at the forefront of the wellness journey. These candies serve as effective liver detoxifiers and stress relievers, offering consumers a 'Dose of Good' with each bite. Available in two convenient packaging options - a 30- candy box and a 60-candy box-they cater to the growing demand for healthy products.

Simultaneously, R3SET is fortifying its pain-management portfolio with the introduction of the R3SET Ultra Potent Gel. This advanced gel, filled in a strikingly luxurious ceramic jar in loos packing with twice the effectiveness of its predecessor, reflects R3SET's commitment to delivering long-term healing solutions for body pain management.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×